Image de couverture de livre

Shine on, you crazy proteins: In silico, design and analysis of chalcone derivatives as dual MAC1/RdRP inhibitors against SARS-CoV-2

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Glaucio, Ferreira
Format:	Recurso digital
Publié:	Zenodo 2026
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS‐CoV‐2 main protease
par: Maryelle A. G. de Carvalho, et autres
Publié: (2024)

Psoralidin acts as a dual protease inhibitor against PL pro and M pro of SARS ‐ CoV ‐2
par: Aditya Trivedi, et autres
Publié: (2025)

An exhaustive computational bioassessment of plant‐derived terpenoids as potential SARS‐CoV‐2 inhibitors
par: Arunkumar Radhakrishnan, et autres
Publié: (2026)

Phthalimide derivatives as a new class of papain‐like protease inhibitors in SARS‐CoV‐2
par: Thomas Fischer, et autres
Publié: (2024)

Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor.
par: Jimeno, Jose, et autres
Publié: (2025)

Involvement of SARS‐CoV‐2 accessory proteins in immunopathogenesis
par: Hayato Ito, et autres
Publié: (2024)

Safety and immunogenicity of vaccines against SARS-CoV-2
par: Francisco Xavier Poveda Paredes
Publié: (2021)

Studies on the synthesis of sugar chalcone derivatives for protein binding
par: Arasappan Hemamalini, et autres
Publié: (2024)

Nanomechanical collective vibration of SARS‐CoV‐2 spike proteins
par: Changfeng Cao, et autres
Publié: (2024)

Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
par: Deborah L Burnett, et autres
Publié: (2026)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
par: Kuldeep Singh Patel
Publié: (2020)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
par: Swapna Thomas, et autres
Publié: (2024)

Structure-based screening of marine carotenoids: fucoxanthin and its derivatives as potential inhibitors of the SARS-CoV-2 nucleocapsid phosphoprotein.
par: Paidi, Murali Krishna, et autres
Publié: (2026)

SARS-CoV-2 and Saliva: an update
par: Muniz, Isis de Araújo Ferreira, et autres
Publié: (2020)

Research progress in Fc‐effector functions against SARS‐CoV‐2
par: Rongyuan Gao, et autres
Publié: (2024)

A peptide derived from SARS‐CoV‐2 nucleocapsid protein with broad‐spectrum anti‐coronavirus activity
par: Guoguo Ye, et autres
Publié: (2024)

Books and arts. Do you sincerely want to go crazy?
Publié: (2002)

Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors
par: Anastasia D. Fomina, et autres
Publié: (2024)

Correlation analysis of the dispersion of SARS-CoV-2 in Mexico
par: López, Pablo Carlos, et autres
Publié: (2026)

Torsional twist of the SARS ‐ CoV and SARS ‐ CoV ‐2 SUD ‐N and SUD ‐M domains
par: Monica Rosas‐Lemus, et autres
Publié: (2025)

Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach
par: Biembengut, Ísis Venturi, et autres
Publié: (2020)

Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS‐CoV‐2
par: Virginia Fuochi, et autres
Publié: (2024)

Structural Immunology of SARS‐CoV‐2
par: Meng Yuan, et autres
Publié: (2024)

Demografía y SARS-CoV-2
par: Manuel Ordorica Mellado
Publié: (2021)

Pandemia por SARS-CoV-2
par: Erina Petrera
Publié: (2020)

Optimization of a DNA‐launched SARS‐CoV‐2 replicon with RNA splicing inhibitor Isoginkgetin
par: Hu Zhang, et autres
Publié: (2024)

SARS ‐ CoV ‐2 nucleocapsid protein variants have differential RNA chaperone activity
par: Sabrina Babl, et autres
Publié: (2025)

SARS-CoV-2 and ACE2 nexus
par: Arifuddin, Mehnaaz Sameera
Publié: (2020)

Phylogeography of horseshoe bat sarbecoviruses in Vietnam and neighbouring countries. Implications for the origins of SARS ‐ CoV and SARS ‐ CoV ‐2
par: Alexandre Hassanin, et autres
Publié: (2024)

Antifungal activity of chalcone derivatives containing 1,2,3,4‐tetrahydroquinoline and studies on them as potential SDH inhibitors
par: Tianyu Deng, et autres
Publié: (2024)

Short‐lived neutralizing activity against SARS‐CoV‐2 in newborns of immunized mothers
par: Marta Stracuzzi, et autres
Publié: (2025)

Exploring essential oils as prospective therapy against the ravaging Coronavirus (SARS-CoV-2)
par: Emmanuel Onah Ojah
Publié: (2020)

HAX1 mediates SARS ‐ CoV ‐2 spike‐triggered unfolded protein response in host cells
par: Fang Zhu, et autres
Publié: (2025)

Spumigins produced by Nodularia spumigena are natural serine protease inhibitors with anti-SARS-CoV-2 activity.
par: Milewska, Aleksandra, et autres
Publié: (2026)

Capillary electrokinetic chromatography for chiral separation of potential SARS‐CoV‐2 3CL protease inhibitors
par: Lucile Brier, et autres
Publié: (2024)

Improved fluorescence‐based assay for rapid screening and evaluation of SARS‐CoV‐2 main protease inhibitors
par: Rui Zhang, et autres
Publié: (2024)

SARS-CoV-2: a clinical update
par: da Silveira Cespedes, Mateus, et autres
Publié: (2020)

COVID-19 y SARS-CoV-2
par: Alfredo Pinzón-Junca
Publié: (2020)

SARS-CoV-2 y aparato digestivo
par: Iván Carabaño Aguado
Publié: (2020)

Non‐Neutralising Antibodies and T Cell Responses to SARS ‐ CoV ‐2 Detected in Unvaccinated SARS ‐ CoV ‐2‐Naive Spanish Adolescents
par: Hector F. Pelaez‐Prestel, et autres
Publié: (2025)